-
1
4th Nuri rocket launch opens up private-led space era in Korea
-
2
‘Unrivaled end-to-end solutions’: Merck aims to anchor Korea’s R&D ecosystem
-
3
EcoPro boosts global footprint with new Hungary plant
-
4
Hanwha unveils W100b Jeju satellite megahub
-
5
SK heiress to head SK Biopharm strategy
-
6
Friends turned rivals: Korean shipbuilding heirs enter MASGA race
-

SK heiress to head SK Biopharm strategy
SK Biopharmaceuticals Vice President Chey Yoon-chung, daughter of SK Group Chair Chey Tae-won, has been appointed to lead the drug-developing company's future strategies, as it seeks to reinforce its execution capabilities and respond proactively to rapidly changing global market conditions. According to SK Biopharmaceuticals on Thursday, Chey, who has headed its business development department, will be in charge of the firm's strategy department starting Jan. 1. The strategy department will ove
Dec. 4, 2025
-

Hanwha unveils W100b Jeju satellite megahub
SEOGWIPO, Jeju Island — Hanwha Systems on Tuesday held an official completion ceremony for the Jeju Space Center on the Hawon Techno Campus located in Seogwipo, Jeju Island, signifying the opening of Korea’s biggest private-led satellite manufacturing facility. With an investment of about 100 billion won ($68 million), Hanwha Systems established the Jeju Space Center with a satellite development and assembly bloc, a satellite function and condition testing facility, a satellite assessment clean
Dec. 2, 2025
-

‘Unrivaled end-to-end solutions’: Merck aims to anchor Korea’s R&D ecosystem
Basic science is regarded as the starting point for numerous industries as it is essential not only to discovering new drugs but also to advancing cutting-edge technologies such as semiconductors and secondary batteries. With a portfolio of about 300,000 reagents and chemicals, Merck, which has been practically “everywhere,” looks to further bolster its presence in Korea. “Our biggest distinction is that we are capable of offering a broad selection of consumables ranging from chemistry to biolog
Nov. 30, 2025
-

EcoPro boosts global footprint with new Hungary plant
EcoPro has completed its cathode materials plant in Debrecen, Hungary, and begun commercial production, becoming the first Korean battery materials maker to establish a manufacturing base in Europe. The company announced Sunday that it had held a completion ceremony on Friday, attended by EcoPro founder Lee Dong-chae, EcoPro CEO Song Ho-jun, EcoPro BM CEO Choi Moon-ho, Hungarian Investment Promotion Agency head Istvan Joo, GEM Vice Chairman Wang Min and SK On CEO Lee Seok-hee, along with other e
Nov. 30, 2025
-

Korens gets cleared of trade secret infringement allegations
Korens, a South Korean automotive parts supplier, has been cleared of a trade secret infringement allegation raised by its crosstown rival SNT Motiv, the company announced Thursday. The Busan High Prosecutors’ Office dismissed an appeal case from SNT Motiv last week, citing that it found no evidence to support SNT Motiv's allegation that Korens illegally obtained the information on adhesive application quantities or drying conditions or leaked the related data to the outside. The prosecution add
Nov. 27, 2025
-

4th Nuri rocket launch opens up private-led space era in Korea
The successful launch of a fourth Nuri rocket from the Naro Space Center in Goheung, South Jeolla Province, early Thursday signified not just further progress in the space industry, but an emphasis on empowering the private sector in the field. Although an abnormal signal from the pressure sensor of the umbilical attached to the rocket delayed the launch by 18 minutes to 1:13 a.m., it eventually deployed 13 satellites into orbit, though not all have made contact with ground control. It was the f
Nov. 27, 2025
-

Friends turned rivals: Korean shipbuilding heirs enter MASGA race
As Korea looks to advance with its "Make American Shipbuilding Great Again," or MASGA, initiative, two chaebol leaders — HD Hyundai Chair Chung Ki-sun and Hanwha Group Vice Chair Kim Dong-kwan — face daunting tasks to successfully enter the United States market and continue to bolster global competitiveness. With the total amount of the investment in the MASGA project set at $150 billion between Seoul and Washington, Kim and Chung — each of them third-generation scions in their early 40s — have
Nov. 26, 2025
-

GS heirs promoted to steer energy-transition push
GS Group announced a sweeping 2026 leadership reshuffle on Wednesday, elevating two core energy business chiefs to vice chairs as the conglomerate prepares for a major strategic reset in the global energy transition. The promotions of Hur Yong-soo, CEO of GS Energy, and Hur Sae-hong, CEO of GS Caltex, to vice chair are the centerpiece of the shake-up. The two executives represent the third and fourth generations of the larger GS and LG founding family lineage, a fact that underscores the group’s
Nov. 26, 2025
-

Samsung invests in China’s Phrontline Biopharma to bolster ADC capability
Samsung said Tuesday it had decided to invest in Phrontline Biopharma, a Chinese biotechnology firm with an antibody-drug conjugate platform and pipeline, through Samsung Life Science Fund. Samsung Life Science Fund was jointly established by Samsung C&T, Samsung Biologics and Samsung Bioepis to discover new technologies and businesses in the biotechnology sector. Although the amount of the investment remained undisclosed, Samsung said it would search for opportunities to strengthen research and
Nov. 25, 2025
-

Samyang Biopharm surges on Kospi debut
Samyang Biopharm, a medical devices and biopharmaceutical affiliate of Samyang Group, soared on the Kospi on Monday as it made its debut on Korea’s main bourse after a spin-off from Samyang Holdings. According to Samyang Biopharm, a total of 7,435,870 shares went public on Kopsi. The listing came after the company had completed the spin-off from Samyang Holdings on Nov. 1. Through a direct listing, Samyang Holdings shareholders received shares of the newly listed biopharmaceutical firm in propor
Nov. 24, 2025



